Status:
ACTIVE_NOT_RECRUITING
Influence of Immobilisation, Stretching and Activity on Morphological and Mechanical Properties of Spastic Muscle
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
University of Graz
Conditions:
Cerebral Palsy, Spastic
Eligibility:
All Genders
5-15 years
Phase:
NA
Brief Summary
Neurologic changes caused by cerebral palsy (CP) result in adaptation of muscle architecture and function (e.g. shortened muscles and contractures). Stretching through immobilization (orthotic treatme...
Eligibility Criteria
Inclusion
- Ambulatory children with spastic CP.
- Ability to accept and follow verbal instruction.
- Limited range of motion in ankle joint - maximal dorsiflexion with knee extended ≤ 5°
- Gross Motor Functional Classification System level I-III.
- Age 5-15 years.
- Willingness to participate.
Exclusion
- Other than spastic form of CP (ataxic, athetoid or dystonic).
- Severe mental retardation.
- Normal range of motion in ankle joint
- Oral antispastic or muscle relaxing medication.
- History of orthopaedic surgery in the last 12 months.
- History of botulinum toxin type A application in the last six months.
Key Trial Info
Start Date :
June 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05269745
Start Date
June 17 2022
End Date
September 30 2024
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Graz
Graz, Styria, Austria, 8036